| Madrigal Pharmaceuticals Inc | 1 993 687 | 1 Md $ | |
| Insmed Inc | 4 842 880 | 791,9 M $ | |
| Protagonist Therapeutics Inc | 5 059 053 | 533,2 M $ | |
| PTC Therapeutics Inc | 7 746 415 | 527,8 M $ | |
| Argenx SE | 709 446 | 518,1 M $ | |
| CG oncology Inc | 6 984 808 | 472,7 M $ | |
| Celcuity Inc | 3 039 621 | 346,9 M $ | |
| Tango Therapeutics Inc | 13 300 620 | 278,2 M $ | |
| Erasca Inc | 16 157 175 | 261,4 M $ | |
| Natera Inc | 1 250 000 | 250 M $ | |
| RadNet Inc | 4 285 000 | 239,5 M $ | |
| Tarsus Pharmaceuticals Inc | 3 346 025 | 234,7 M $ | |
| Apogee Therapeutics Inc | 2 782 097 | 234,2 M $ | |
| Spyre Therapeutics Inc | 4 171 996 | 210,4 M $ | |
| Cogent Biosciences Inc | 5 458 675 | 210,1 M $ | |
| IRhythm Holdings Inc | 1 668 500 | 196,9 M $ | |
| Stoke Therapeutics Inc | 5 623 525 | 183,1 M $ | |
| Cytokinetics Inc | 2 721 158 | 179,4 M $ | |
| ACADIA Pharmaceuticals Inc | 7 144 524 | 159 M $ | |
| Apellis Pharmaceuticals Inc | 3 685 045 | 148,2 M $ | |
| Immunocore Holdings PLC | 4 869 798 | 146,8 M $ | |
| Repligen Corp | 1 206 000 | 142,1 M $ | |
| Neurocrine Biosciences Inc | 1 062 072 | 139,9 M $ | |
| Guardant Health Inc | 1 481 033 | 136,8 M $ | |
| ZAI LAB LTD | 6 574 032 | 123,7 M $ | |
| Belite Bio Inc | 715 332 | 114,1 M $ | |
| Intuitive Surgical Inc | 220 000 | 101,4 M $ | |
| Oruka Therapeutics Inc | 2 058 148 | 101 M $ | |
| Xencor Inc | 6 777 461 | 81,7 M $ | |
| CENTESSA PHARMACEUTICALS PLC | 2 054 175 | 81,6 M $ | |
| Immunovant Inc | 3 177 849 | 78,9 M $ | |
| Ultragenyx Pharmaceutical Inc | 3 648 795 | 76,4 M $ | |
| Hinge Health Inc | 1 930 000 | 74,4 M $ | |
| Castle Biosciences Inc | 2 758 335 | 67,7 M $ | |
| Rocket Pharmaceuticals Inc | 17 687 772 | 63,3 M $ | |
| Taysha Gene Therapies Inc | 13 680 248 | 61,2 M $ | |
| Compass Pathways plc | 10 632 390 | 58,8 M $ | |
| Kodiak Sciences Inc | 1 487 934 | 56,7 M $ | |
| Replimune Group Inc | 7 356 916 | 56,3 M $ | |
| Crinetics Pharmaceuticals Inc | 1 451 326 | 52,7 M $ | |
| Waystar Holding Corp | 1 630 000 | 39,3 M $ | |
| Arrowhead Pharmaceuticals Inc | 585 682 | 36,7 M $ | |
| Orchestra BioMed Holdings Inc | 8 306 063 | 35,3 M $ | |
| Verastem Inc | 6 576 306 | 34,9 M $ | |
| Evommune Inc | 1 502 235 | 34,5 M $ | |
| Stryker Corp | 100 000 | 32,9 M $ | |
| Savara Inc | 5 952 380 | 32,5 M $ | |
| Candel Therapeutics Inc | 6 422 018 | 31,5 M $ | |
| Aquestive Therapeutics Inc | 7 426 471 | 30,8 M $ | |
| Aktis Oncology Inc | 1 592 043 | 28,5 M $ | |
| Neurogene Inc | 1 362 456 | 27,5 M $ | |
| Cullinan Therapeutics Inc | 1 705 960 | 24,2 M $ | |
| Compass Therapeutics Inc | 4 186 599 | 22,1 M $ | |
| Dianthus Therapeutics Inc | 248 063 | 20,8 M $ | |
| Fulgent Genetics Inc | 1 289 000 | 20,5 M $ | |
| Beta Bionics Inc | 2 000 000 | 20 M $ | |
| Kymera Therapeutics Inc | 240 000 | 20 M $ | |
| Century Therapeutics Inc | 8 695 652 | 19,7 M $ | |
| Beam Therapeutics Inc | 570 394 | 13,6 M $ | |
| AVALO THERAPEUTICS INC | 856 962 | 12,8 M $ | |
| Ocugen Inc | 6 666 666 | 12,1 M $ | |
| HeartFlow Inc | 495 000 | 12 M $ | |
| JADE BIOSCIENCES INC | 573 205 | 8,1 M $ | |
| Capricor Therapeutics Inc | 250 000 | 7,6 M $ | |
| KALARIS THERAPEUTICS INC | 1 300 000 | 7,5 M $ | |
| Inventiva SACA | 1 298 702 | 7,2 M $ | |
| AtaiBeckley Inc | 2 000 000 | 7,1 M $ | |
| Larimar Therapeutics Inc | 1 500 000 | 6,8 M $ | |
| Tenax Therapeutics Inc | 370 246 | 5,9 M $ | |
| Lumexa Imaging Holdings Inc | 650 000 | 5,6 M $ | |
| 4D Molecular Therapeutics Inc | 475 737 | 4,4 M $ | |
| Medline Inc | 70 000 | 3,1 M $ | |
| Omada Health Inc | 200 000 | 2,5 M $ | |
| Disc Medicine Inc | 30 000 | 1,9 M $ | |
| IMAGENEBIO INC | 334 445 | 1,7 M $ | |
| Exagen Inc | 395 231 | 1,2 M $ | |